Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Rhythm: Beloved electrophysiologist killed in accident | FDA's recall update | EP studies during TAVR
Friday, September 29, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

Cardiologist killed in bicycle accident remembered as a ‘talented and compassionate’ electrophysiologist

According to a loving tribute from Methodist Health System, Matthew Latacha, MD, was “well respected, admired and loved by patients, colleagues and staff.” The incident is still under investigation. 

READ MORE >
Matthew Latacha, MD, Methodist Health System, cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist killed in bicycle accident remembered as a ‘talented and compassionate’ electrophysiologist

Share on Twitter Share on Facebook Share on Linkedin
Matthew Latacha, MD, Methodist Health System, cardiologist
According to a loving tribute from Methodist Health System, Matthew Latacha, MD, was “well respected, admired and loved by patients, colleagues and staff.” The incident is still under investigation. 
READ MORE >

AFib recurrence during the 90-day blanking period after ablation—nothing serious or a sign of trouble?

Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 

READ MORE >
ECG rhythm strip from a 6-lead ECG
Share on Twitter Share on Facebook Share on Linkedin

AFib recurrence during the 90-day blanking period after ablation—nothing serious or a sign of trouble?

Share on Twitter Share on Facebook Share on Linkedin
ECG rhythm strip from a 6-lead ECG
Asking patients to use smartphone-powered ECG devices following catheter ablation procedures could be incredibly beneficial, according to new findings published in JACC: Clinical Electrophysiology. 
READ MORE >

FDA shares update on heart devices linked to multiple recalls and patient deaths

The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA shares update on heart devices linked to multiple recalls and patient deaths

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The devices, designed to provide temporary support to a patient's left ventricle, have been associated with a long list of issues in recent months. 
READ MORE >

EP studies during TAVR are safe and effective, new pilot study confirms

New research in JACC: Cardiovascular Interventions explored the potential of performing EP studies before and after valve deployment. TAVR operators handled all catheter manipulations, and EP specialists were on hand to capture the necessary measurements. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

EP studies during TAVR are safe and effective, new pilot study confirms

Share on Twitter Share on Facebook Share on Linkedin
New research in JACC: Cardiovascular Interventions explored the potential of performing EP studies before and after valve deployment. TAVR operators handled all catheter manipulations, and EP specialists were on hand to capture the necessary measurements. 
READ MORE >

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

READ MORE >
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Share on Twitter Share on Facebook Share on Linkedin

Pulsed field ablation shows potential to replace thermal ablation

Share on Twitter Share on Facebook Share on Linkedin
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 
READ MORE >

Cooling device now approved by FDA to reduce risk of ablation-related esophageal injuries

Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures. 

READ MORE >
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
Share on Twitter Share on Facebook Share on Linkedin

Cooling device now approved by FDA to reduce risk of ablation-related esophageal injuries

Share on Twitter Share on Facebook Share on Linkedin
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures. 
READ MORE >

Another long-term benefit of AFib ablation: Improved mental health

A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.

READ MORE >
cardiologist preparing to perform radiofrequency ablation
Share on Twitter Share on Facebook Share on Linkedin

Another long-term benefit of AFib ablation: Improved mental health

Share on Twitter Share on Facebook Share on Linkedin
cardiologist preparing to perform radiofrequency ablation
A new study published in JAMA suggests catheter ablation can help AFib patients experience fewer feelings of depression and anxiety.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup